At a glance
- Originator Johnson & Johnson
- Class Antihypertensives; Ischaemic heart disorder therapies; Peripheral vasodilators; Small molecules
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension; Myocardial ischaemia
Most Recent Events
- 19 Aug 1997 Suspended-Preclinical for Hypertension in USA (Unknown route)
- 19 Aug 1997 Suspended-Preclinical for Myocardial ischaemia in USA (Unknown route)
- 26 Jun 1995 Investigation in Hypertension in USA (Unknown route)